The low base rate of severe adverse drug events places clinical-outcome effects beyond the scope of a single-site feasibility study

We explicitly do not claim a clinical-outcome effect, which the low base rate of severe events places beyond a single-site feasibility study.

http://arxiv.org/abs/2608.27239v1